Soleno Therapeutics (SLNO) Free Cash Flow (2016 - 2019)
Historic Free Cash Flow for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to -$5.1 million.
- Soleno Therapeutics' Free Cash Flow fell 3592.83% to -$5.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$17.4 million, marking a year-over-year decrease of 4881.09%. This contributed to the annual value of -$69.3 million for FY2024, which is 17793.91% down from last year.
- According to the latest figures from Q4 2019, Soleno Therapeutics' Free Cash Flow is -$5.1 million, which was down 3592.83% from -$4.7 million recorded in Q3 2019.
- Soleno Therapeutics' Free Cash Flow's 5-year high stood at -$1.8 million during Q1 2015, with a 5-year trough of -$5.1 million in Q4 2019.
- For the 5-year period, Soleno Therapeutics' Free Cash Flow averaged around -$3.2 million, with its median value being -$2.8 million (2016).
- Per our database at Business Quant, Soleno Therapeutics' Free Cash Flow tumbled by 25559.92% in 2015 and then skyrocketed by 4536.6% in 2017.
- Over the past 5 years, Soleno Therapeutics' Free Cash Flow (Quarter) stood at -$3.1 million in 2015, then increased by 14.43% to -$2.7 million in 2016, then dropped by 1.87% to -$2.7 million in 2017, then plummeted by 36.82% to -$3.7 million in 2018, then crashed by 35.93% to -$5.1 million in 2019.
- Its Free Cash Flow was -$5.1 million in Q4 2019, compared to -$4.7 million in Q3 2019 and -$3.9 million in Q2 2019.